Charles Schwab Investment Management Inc Karyopharm Therapeutics Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 51,000 shares of KPTI stock, worth $38,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,000
Previous 309,909
83.54%
Holding current value
$38,250
Previous $467,000
90.58%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding KPTI
# of Institutions
120Shares Held
64.9MCall Options Held
500KPut Options Held
99K-
Vanguard Group Inc Valley Forge, PA7.65MShares$5.74 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.1MShares$3.83 Million0.56% of portfolio
-
Eversept Partners, LP New York, NY4.99MShares$3.74 Million0.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.32MShares$3.24 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$3.13 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $59.9M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...